Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment.

Mathews RJ, Robinson JI, Battellino M, Wong C, Taylor JC; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Eyre S, Churchman SM, Wilson AG, Isaacs JD, Hyrich K, Barton A, Plant D, Savic S, Cook GP, Sarzi-Puttini P, Emery P, Barrett JH, Morgan AW, McDermott MF.

Ann Rheum Dis. 2014 Jun;73(6):1202-10. doi: 10.1136/annrheumdis-2013-203276. Epub 2013 May 17.

PMID:
23687262
2.

High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P, Zhernakova A, Stahl E, Viatte S, McAllister K, Amos CI, Padyukov L, Toes RE, Huizinga TW, Wijmenga C, Trynka G, Franke L, Westra HJ, Alfredsson L, Hu X, Sandor C, de Bakker PI, Davila S, Khor CC, Heng KK, Andrews R, Edkins S, Hunt SE, Langford C, Symmons D; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate; Wellcome Trust Case Control Consortium, Concannon P, Onengut-Gumuscu S, Rich SS, Deloukas P, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Ärlsetig L, Martin J, Rantapää-Dahlqvist S, Plenge RM, Raychaudhuri S, Klareskog L, Gregersen PK, Worthington J.

Nat Genet. 2012 Dec;44(12):1336-40. doi: 10.1038/ng.2462. Epub 2012 Nov 11.

3.

Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritis.

Fisher BA, Plant D, Lundberg K, Charles P, Barton A, Venables PJ; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS).

J Rheumatol. 2012 May;39(5):929-32. doi: 10.3899/jrheum.111315. Epub 2012 Apr 1.

PMID:
22467927
4.
5.

Endorsement of peer review.

John H, Erb N, Rowe IF.

Clin Med (Lond). 2010 Dec;10(6):639-40. No abstract available.

PMID:
21416672
6.

Eight years' experience of regional audit: an assessment of its value as a clinical governance tool.

John H, Paskins Z, Hassell A, Rowe IF; West Midlands Rheumatology Service and Training Committee.

Clin Med (Lond). 2010 Feb;10(1):20-5.

PMID:
20408300
7.
8.

Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.

Hassan B, Maxwell JR, Hyrich KL; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, Barton A, Worthington J, Isaacs JD, Morgan AW, Wilson AG.

Rheumatology (Oxford). 2010 Jan;49(1):43-7. doi: 10.1093/rheumatology/kep372. Epub 2009 Nov 19.

9.

Regional survey of tuberculosis risk assessment in rheumatology outpatients commencing anti-TNF-alpha treatment in relation to British Thoracic Society guidelines.

John H, Buckley C, Koh L, Obrenovic K, Erb N, Rowe IF; West Midlands Rheumatology Service and Training Committee.

Clin Med (Lond). 2009 Jun;9(3):225-30.

PMID:
19634383
10.

Piloting education days for patients with early rheumatoid arthritis and their partners: a multidisciplinary approach.

Ellard DR, Barlow JH, Paskins Z, Stapley J, Wild A, Rowe IF.

Musculoskeletal Care. 2009 Mar;7(1):17-30. doi: 10.1002/msc.137.

PMID:
18688791
11.

Comment on: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists.

Sandhu RS, Treharne GJ, Justice EA, Jordan AC, Saravana S, Obrenovic K, Erb N, Kitas GD, Rowe IF; West Midlands Rheumatology Services and Training Committee.

Rheumatology (Oxford). 2008 Apr;47(4):559-60; author reply 560. doi: 10.1093/rheumatology/ken031. Epub 2008 Mar 7. No abstract available.

12.

Accessibility and quality of secondary care rheumatology services for people with inflammatory arthritis: a regional survey.

Sandhu RS, Treharne GJ, Justice EA, Jordan AC, Saravana S, Obrenovic K, Erb N, Kitas GD, Rowe IF; West Midlands Rheumatology Services and Training Committee.

Clin Med (Lond). 2007 Dec;7(6):579-84.

PMID:
18193705
13.

Patients' own ability to assess activity of their rheumatoid arthritis.

Potter T, Wild A, Edwards K, Rai A, Rowe IF.

Rheumatology (Oxford). 2006 Aug;45(8):1044. Epub 2006 May 22. No abstract available.

14.

Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands.

Paskins Z, Potter T, Erb N, Obrenovic K, Rowe IF; West Midlands Rheumatology Services and Training Committee.

Clin Med (Lond). 2006 Mar-Apr;6(2):183-7.

PMID:
16688979
15.

Experience of six years of a regional peer review scheme in rheumatology.

Piper H, Hassell AB, Rowe IF, Delamere J; West Midlands Rheumatology Service and Training Committee.

Rheumatology (Oxford). 2006 Sep;45(9):1110-5. Epub 2006 Mar 1.

16.
17.

Acute atrioventricular node block requiring cardiac pacing in Cogan's syndrome.

Erb N, Sinha A, Slaney PL, Rowe IF.

Rheumatology (Oxford). 2003 Sep;42(9):1126-8. No abstract available.

18.

The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study.

Yee CS, Filer A, Pace A, Douglas K, Situnayake D, Rowe IF; West Midlands Rheumatology Services and Training Committee.

Rheumatology (Oxford). 2003 Jul;42(7):856-9. Epub 2003 Mar 31.

19.

A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands.

Erb N, Duncan RC, Raza K, Rowe IF, Kitas GD, Situnayake RD; West Midlands Rheumatology Services and Training Committee.

Rheumatology (Oxford). 2002 Sep;41(9):1021-4.

20.

Educational preferences, psychological well-being and self-efficacy among people with rheumatoid arthritis.

Barlow JH, Cullen LA, Rowe IF.

Patient Educ Couns. 2002 Jan;46(1):11-9.

PMID:
11804765
Items per page

Supplemental Content

Loading ...
Write to the Help Desk